1. Home
  2. GDTC vs IZM Comparison

GDTC vs IZM Comparison

Compare GDTC & IZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • IZM
  • Stock Information
  • Founded
  • GDTC 2018
  • IZM 2011
  • Country
  • GDTC Singapore
  • IZM China
  • Employees
  • GDTC N/A
  • IZM N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • IZM Consumer Electronics/Video Chains
  • Sector
  • GDTC Health Care
  • IZM Consumer Discretionary
  • Exchange
  • GDTC Nasdaq
  • IZM Nasdaq
  • Market Cap
  • GDTC 28.0M
  • IZM 28.7M
  • IPO Year
  • GDTC 2023
  • IZM 2023
  • Fundamental
  • Price
  • GDTC $2.21
  • IZM $2.58
  • Analyst Decision
  • GDTC Buy
  • IZM
  • Analyst Count
  • GDTC 1
  • IZM 0
  • Target Price
  • GDTC $5.00
  • IZM N/A
  • AVG Volume (30 Days)
  • GDTC 6.5K
  • IZM 31.4K
  • Earning Date
  • GDTC 01-01-0001
  • IZM 07-25-2025
  • Dividend Yield
  • GDTC N/A
  • IZM N/A
  • EPS Growth
  • GDTC N/A
  • IZM N/A
  • EPS
  • GDTC N/A
  • IZM N/A
  • Revenue
  • GDTC $368,838.00
  • IZM $180,553,977.00
  • Revenue This Year
  • GDTC $5.37
  • IZM N/A
  • Revenue Next Year
  • GDTC N/A
  • IZM N/A
  • P/E Ratio
  • GDTC N/A
  • IZM N/A
  • Revenue Growth
  • GDTC N/A
  • IZM N/A
  • 52 Week Low
  • GDTC $1.20
  • IZM $1.18
  • 52 Week High
  • GDTC $4.05
  • IZM $3.19
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 49.36
  • IZM 59.08
  • Support Level
  • GDTC $2.09
  • IZM $2.50
  • Resistance Level
  • GDTC $2.35
  • IZM $2.74
  • Average True Range (ATR)
  • GDTC 0.10
  • IZM 0.10
  • MACD
  • GDTC 0.00
  • IZM -0.00
  • Stochastic Oscillator
  • GDTC 50.00
  • IZM 73.68

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About IZM ICZOOM Group Inc.

ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.

Share on Social Networks: